Get the Stockscreener App
62.98
6.99%
4.115
After Hours:
63.50
0.52
+0.83%
Tempus Ai Inc stock is traded at $62.98, with a volume of 680.21K.
It is up +6.99% in the last 24 hours and up +44.75% over the past month.
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
See More
Previous Close:
$58.87
Open:
$61
24h Volume:
680.21K
Relative Volume:
0.59
Market Cap:
$10.01B
Revenue:
$640.44M
Net Income/Loss:
$-743.28M
P/E Ratio:
-
EPS:
-
Net Cash Flow:
$-206.93M
1W Performance:
+8.31%
1M Performance:
+44.75%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$61.00
$65.34
1-Week Range:
$52.09
$67.46
52-Week Range:
$22.89
$79.49
Tempus Ai Inc Stock (TEM) Company Profile
Name
Tempus Ai Inc
Sector
Industry
Phone
800-976-5448
Address
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
62.98 | 10.01B | 640.44M | -743.28M | -206.93M | 0.00 |
|
VEEV
Veeva Systems Inc
|
226.76 | 36.93B | 2.57B | 615.26M | 996.76M | 3.32 |
|
SOLV
Solventum Corp
|
72.48 | 12.43B | 8.26B | 66.00M | 1.17B | 0.00 |
|
DOCS
Doximity Inc
|
53.39 | 9.94B | 493.63M | 160.55M | 162.20M | 0.55 |
|
HQY
Healthequity Inc
|
102.47 | 8.91B | 1.10B | 105.67M | -197.98M | 0.1475 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-11-24 | Downgrade | Stifel | Buy → Hold |
| Oct-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-12-24 | Initiated | Piper Sandler | Neutral |
| Jul-09-24 | Initiated | BofA Securities | Buy |
| Jul-09-24 | Initiated | JP Morgan | Overweight |
| Jul-09-24 | Initiated | Longbow | Buy |
| Jul-09-24 | Initiated | Loop Capital | Buy |
| Jul-09-24 | Initiated | Morgan Stanley | Overweight |
| Jul-09-24 | Initiated | Needham | Buy |
| Jul-09-24 | Initiated | Stifel | Buy |
| Jul-09-24 | Initiated | TD Cowen | Buy |
| Jul-09-24 | Initiated | William Blair | Outperform |
View All
Tempus Ai Inc Stock (TEM) Latest News
Will Ambry Genetics Acquisition Drive Tempus AI's Prospects? - MSN
Tempus AI CEO to Present at Piper Sandler Healthcare Conference in December | TEM Stock News - StockTitan
Tempus to Participate in the Piper Sandler 36th Annual Healthcare Conference - Business Wire
Medtronic, Tempus testing AI to find potential TAVR patients - Yahoo Finance
Tempus AI (NASDAQ:TEM) Trading Up 7.6%Should You Buy? - MarketBeat
Gene Panel Market to Surpass USD 11.75 Billion by 2031 | SkyQuest Technology - GlobeNewswire Inc.
Cathie Wood's ARK buys Tempus AI stock, sells Exact Sciences By Investing.com - Investing.com Canada
Cathie Wood's ARK buys Tempus AI stock, sells Exact Sciences - Investing.com India
Items Tagged with 'Tempus AI Inc.' - BioWorld Online
Medtronic, Tempus ALERT to disparities in valve replacement - BioWorld Online
Tempus AI stock jumps 14% following $411M IPO - MSN
Tempus Stock Declines Despite Q3 Earnings & Revenues Beat Estimates - MSN
Tempus AI, Inc. (NASDAQ:TEM) Q3 2024 Earnings Call Transcript - MSN
Tempus AI downgraded to hold by Stifel, valuation cited - MSN
Cathie Wood's ARK ETFs Adjust Portfolio with Notable Tesla and Tempus AI Stock Trades - Investing.com Nigeria
Tempus AI, Inc agreed to acquire Ambry Genetics Corporation from REALM IDx, Inc. for approximately $600 million. - Marketscreener.com
Short Interest in Tempus AI, Inc. (NASDAQ:TEM) Rises By 19.2% - MarketBeat
Behind the Scenes of Tempus AI's Latest Options Trends - Benzinga
Sumitomo Mitsui Trust Group Inc. Buys 1,145,698 Shares of Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
AI Health Care Co. Can't Sink Ex-Worker's Sex Bias Claims - Law360
U.S. Indexes Dropped Thursday; Tempus AI Took Biggest Hit - Barron's
Sigma Planning Corp Acquires Shares of 23,369 Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
Piper Sandler raises Tempus AI stock target by 75%, keeps Neutral rating after earnings - Investing.com
Tempus AI: Pioneering the Future of Precision Medicine Through AI-Driven Innovation (TEM) - Seeking Alpha
U.S. Indexes Declined Tuesday; Tempus AI Fell Furthest - Barron's
Tempus AI's (TEM) "Neutral" Rating Reaffirmed at Piper Sandler - MarketBeat
Tempus AI (NASDAQ:TEM) Sets New 12-Month HighHere's What Happened - MarketBeat
Tempus Partners with Flatiron Health, Brings Genomic Testing to 800+ Cancer Centers | TEM Stock News - StockTitan
Stifel cuts Tempus AI stock to Hold, lifts PT on Ambry Genetics deal - Investing.com Australia
Tempus AI (NASDAQ:TEM) Shares Gap DownHere's Why - MarketBeat
Tempus Announces Nine Abstracts Accepted for Presentation at the 2024 Society for Immunotherapy of Cancer Annual Meeting - Marketscreener.com
Tempus Publishes Study Highlighting Benefits of Concurrent RNA and DNA Sequencing in Advanced Cancer Care - Business Wire
Tempus AI (NASDAQ:TEM) Cut to "Hold" at Stifel Nicolaus - MarketBeat
Tempus AI, Inc. (NASDAQ:TEM) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Tempus AI to Buy Ambry Genetics for $600M - Orange County Business Journal
ARK Investment Management LLC Raises Holdings in Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
Tempus AI Inc (NASDAQ:TEM) Continues Strong Growth with 33% Revenue Increase, Price Target Raised to $56 - Insider Monkey
Tempus Announces the Clinical Launch of its Immune Profile Score Algorithmic Test - 01Net
10 AI News You Shouldn’t Miss - Insider Monkey
Exciting Growth Potential Ahead for Tempus AI (TEM) - Insider Monkey
Tempus AI’s $600 Million Acquisition of Ambry Genetics - Global Legal Chronicle
Tempus AI to buy genetic testing company for $600M - MedTech Dive
Ambry Genetics Being Acquired by Tempus AI for $600M - Orange County Business Journal
Tempus AI (NASDAQ:TEM) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Needham raises Tempus AI stock target on Q3 results, acquisition By Investing.com - Investing.com Australia
Needham raises Tempus AI stock target on Q3 results, acquisition - Investing.com India
Tempus: Q3 Earnings Snapshot - The Advocate
Tempus Ai Inc Stock (TEM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.28%
1.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):